We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01458405
Recruitment Status : Terminated (On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR trial to focus resourcing on its active CAP-1002 program, HOPE-2.)
First Posted : October 24, 2011
Last Update Posted : April 9, 2019
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
Capricor Inc.